phosphorylcholine has been researched along with fluorodeoxyglucose f18 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altmann, A; Berger, MR; Dimitrakopoulou, A; Haberkorn, U; Oberdorfer, F; Reinhardt, M; Strauss, LG; van Kaick, G; Wallich, R | 1 |
| De Moliner, P; Maziere, B; Ottaviani, M; Remy, P; Samson, Y | 1 |
| Go, KG; Heesters, MA; Kamman, RL; Mooyaart, EL; Paans, AM; Pruim, J; Vaalburg, W | 1 |
| Balkay, L; Krasznai, Z; Krasznai, ZT; Márián, T; Szabó-Péli, J; Trón, L | 1 |
| Atkinson, E; Bast, RC; Coleman, RL; Coombes, KR; Dice, K; Dyer, M; Fu, S; Gershenson, DM; Hennessy, BT; Howard, A; Jackson, E; Ju, Z; Kavanagh, JJ; Kundra, V; Kurzrock, R; Levenback, CF; Li, J; Li, Y; Markman, M; Mills, GB; Ng, CS; Sood, AK; Stemke-Hale, K; Wolf, JK | 1 |
1 trial(s) available for phosphorylcholine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Grading; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Phosphorylcholine; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Taxoids | 2012 |
4 other study(ies) available for phosphorylcholine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromatography, High Pressure Liquid; Deoxyglucose; Drug Screening Assays, Antitumor; Fluorodeoxyglucose F18; Humans; Phosphorylcholine; Tomography, Emission-Computed; Tumor Cells, Cultured | 1992 |
Effect of alpha-glyceril-phosphorylcholine on cerebral glucose metabolism in normal volunteers.
Topics: Brain; Brain Chemistry; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Parasympathomimetics; Phosphorylcholine; Platelet Activating Factor; Tomography, Emission-Computed | 1992 |
Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography.
Topics: Aspartic Acid; Brain; Brain Chemistry; Brain Edema; Carbon Radioisotopes; Creatine; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Lactates; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Phosphorylcholine; Supratentorial Neoplasms; Tomography, Emission-Computed; Tyrosine | 1995 |
Effects of miltefosine on membrane permeability and accumulation of [99mTc]-hexakis-2-methoxyisobutyl isonitrile, 2-[18F]fluoro-2-deoxy-D-glucose, daunorubucin and rhodamine123 in multidrug-resistant and sensitive cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane Permeability; Daunorubicin; Drug Resistance, Multiple; Fluorodeoxyglucose F18; Humans; Membrane Fluidity; Mice; NIH 3T3 Cells; Phosphorylcholine; Rhodamine 123; Technetium Tc 99m Sestamibi; Verapamil | 2005 |